Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Argonaut announced the California Department of Public Health, FDB has inspected and approved Argonaut’s new Drug Product Manufacturing facility.
read more
Wednesday, February 26, 2020
Argonaut Manufacturing Services and Particle Measuring Systems (PMS) have announced their ongoing partnership.
read more
ArisGlobal announced LifeSphere® Publishing, a complete, pre-validated submissions management system.
read more
Wednesday, February 12, 2025
ArisGlobal announced its signing of the European Union’s AI Pact agreement. The public pledge promotes responsible and ethical AI development and deployment, underpinning AI’s “bigger picture”: its benefits to society.
read more
Wednesday, March 01, 2023
ArisGlobal, a leading provider of life sciences software designed to automate core drug development functions with its end-to-end technology platform LifeSphere® announced the acquisition of Amplexor Life Sciences (LS), a global provider of ...
read more
Arkivum has achieved pharma-level compliance with the award of ISO 9001:2015 certification, demonstrated alignment with data-related GxP regulations.
read more
Tuesday, September 23, 2025
Arkivum announced a new partnership with PHARMASEAL, the provider of the Engility® Trial Management Platform, consisting of a Clinical Trial Management System (CTMS) and Electronic Trial Master File (eTMF).
read more
Armas Pharmaceuticals and Micro Labs USA have announced the forming of a strategic collaboration to bring select multisource injectable products to the U.S. market.
read more
Wednesday, April 11, 2012
Esther Sadler-Williams, Senior Director Strategic Alliance Development, Clinical Supply Services at Catalent Pharma Solutions will lead two discussions, “Around the World in 80 Ways: How to Ensure a Lean and Efficient Clinical Distribution Supply ...
read more
Wednesday, March 10, 2021
Arranta Bio announced the addition of a 130,000-square-foot facility in Boxborough, Massachusetts, to complement its existing facilities.
read more
Wednesday, November 17, 2021
Arranta Bio (“Arranta”), a leading contract development and manufacturing organization (CDMO) supporting advanced therapy pioneers, today announced the completion of the sale of its process development and GMP clinical manufacturing site in ...
read more
Wednesday, April 24, 2019
Arrowhead has begun dosing in a new triple combination cohort that includes JNJ-3989 and additional undisclosed agents selected by Janssen in its ongoing Phase 1/2 study in patients with chronic HBV.
read more
Wednesday, August 01, 2018
Arrowhead Pharmaceuticals has earned a $10 million milestone payment from Amgen following the administration of the first dose of AMG 890, formerly referred to as ARO-LPA, in a clinical study.
read more
Arsenal Capital Partners has agreed to sell its portfolio company, Certara to EQT VII Fund for an enterprise value of $850 million.
read more
Wednesday, February 26, 2020
Arsenal has announced the acquisition of BresMed, a provider of health economic research, communications, and consulting services.
read more